
UBITECH is proud to announce its participation in GENz-trials, an ambitious new project funded under the Innovative Health Initiative Joint Undertaking (IHI JU) under Grant Agreement No. 101252995. The project officially launched with its Kick-off Meeting held on 26–27 February 2026 in Thessaloniki, Greece, hosted by the coordinating partner Aristotle University of Thessaloniki (AUTH). Spanning 48 months (January 2026 – December 2029), GENz-trials brings together a multidisciplinary European consortium committed to fundamentally rethinking the clinical trial paradigm through data science, AI automation, and simulation technologies. As a matter of fact, UBITECH participates in this next-generation IHI-funded clinical trial initiative that harnesses federated AI, digital twins, and synthetic control arms to transform how clinical research is designed, conducted, and evaluated across Europe.
Continue reading UBITECH Joins the GENz-trials IHI-funded Initiative to Revolutionize Clinical Trials and Optimize Assessment of Healthcare Innovations










